FDA Greenlights J&J's Varipulse Device for Safer Atrial Fibrillation Treatment

By Yahoo! Finance | Nov 7, 2024 at 02:57 PM EST

Johnson & Johnson's Varipulse device, approved by the FDA for treating atrial fibrillation, combines Carto 3 system and pulsed-field ablation. It enhances ablation accuracy, reduces radiation exposure, and offers high success rates in treating patients based on the admIRE trial results.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.